The moderate/severe-AMS group experienced increases of 0.7 × 1012/L in RBC, 20.8 g/L in Hb, and 7.8% in HCT (P < 0.01; Figs. 1–3, and Table 2). Here, GSTM1 is linked to ablepharon macrostomia syndrome.